Trotana, Inc.
Biotechnology ResearchCalifornia, United States11-50 Employees
Trotana is developing novel oral anti-inflammatory medicines
Growing Innovation Trotana is focused on developing novel oral anti-inflammatory medicines, indicating potential partnerships with healthcare providers and pharmaceutical companies seeking innovative treatments in the inflammation space.
Small-Scale Yet Agile With an employee base of 11-50 and revenue ranging from 1M to 10M dollars, Trotana presents an opportunity for personalized and flexible collaborations, especially for niche or emerging biotech products.
Technology Utilization Trotana's use of cloud services and modern web frameworks showcases its readiness to support scalable digital collaborations and data sharing, facilitating efficient communication with potential partners.
Market Positioning Operating in a highly competitive biotech landscape with industry giants suggests opportunities in strategic alliances, licensing, or co-development to leverage Trotana’s innovative pipeline.
Funding and Revenue Potential While current funding details are unspecified, the revenue indication underscores a growth trajectory, making Trotana a promising candidate for investment or partnership to accelerate product development.
Trotana, Inc. uses 6 technology products and services including Wix, Google Cloud, React, and more. Explore Trotana, Inc.'s tech stack below.
| Trotana, Inc. Email Formats | Percentage |
| FLast@trotana.com | 89% |
| FirLast@trotana.com | 6% |
| First.Last@trotana.com | 2% |
| FirstLas@trotana.com | 3% |
Biotechnology ResearchCalifornia, United States11-50 Employees
Trotana is developing novel oral anti-inflammatory medicines
Trotana, Inc.'s revenue is estimated to be in the range of $10M$25M
Trotana, Inc.'s revenue is estimated to be in the range of $10M$25M